Frequently Asked Questions
Common Questions About Using ICD-10 Code C83.5A for Lymphoblastic (diffuse) lymphoma, in remission
What does it mean if a patient is in remission?
Being in remission means that the signs and symptoms of Lymphoblastic (diffuse) lymphoma have significantly decreased or disappeared following treatment. Regular monitoring is essential to ensure that the disease does not return.
How is remission confirmed?
Remission is typically confirmed through clinical evaluations, imaging studies, and laboratory tests that show no evidence of disease activity, such as normal blood counts and imaging results.
What are the follow-up procedures for patients in remission?
Patients in remission should have regular follow-up appointments, including physical exams and blood tests, to monitor for any signs of relapse and to manage any long-term effects of treatment.
Can patients in remission still experience symptoms?
Yes, patients in remission may still experience symptoms related to treatment side effects or other health issues. It is important for them to communicate any new or persistent symptoms to their healthcare provider.
